3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lung Neoplasms
8
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Anus Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Smoking
1
Recurrence
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Myocarditis
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoproliferative Disorders
1
Interventions
Cyclophosphamide
13
Prednisone
10
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
9
Doxorubicin
9
Vincristine
8
Azacitidine
6
romidepsin
5
Gemcitabine
5
Brentuximab Vedotin
5
fludarabine
4
Etoposide
4
Dexamethasone
4
pembrolizumab
3
belinostat
3
Lenalidomide
3
Biopsy
3
10-propargyl-10-deazaaminopterin
3
tazemetostat
2
ruxolitinib
2
ixazomib
2
duvelisib
2
Nivolumab
2
Bendamustine Hydrochloride
2
venetoclax
1
tislelizumab
1
thymoglobulin
1
spartalizumab
1
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
sintilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Tomography, X-Ray Computed
×
1 year
×
Clear all
NCT06362148
2026-05-01
CIRCULATE
University of Aarhus
Active not recruiting
50 enrolled